Deferred Tax Assets, Valuation Allowance of IGM Biosciences, Inc. from 31 Dec 2018 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
IGM Biosciences, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2018 to 31 Dec 2024.
  • IGM Biosciences, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $301,060,000, a 13% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

IGM Biosciences, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $301,060,000 +$33,598,000 +13% 31 Dec 2024 10-K 06 Mar 2025 2024 FY
Q4 2023 $267,462,000 +$78,268,000 +41% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q4 2022 $189,194,000 +$68,792,000 +57% 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q4 2021 $120,402,000 +$58,428,000 +94% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q4 2020 $61,974,000 +$29,931,000 +93% 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q4 2019 $32,043,000 +$12,406,000 +63% 31 Dec 2019 10-K 30 Mar 2021 2020 FY
Q4 2018 $19,637,000 31 Dec 2018 10-K 26 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.